|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02335 MICOT PHARMA-B
Nominal 
21.980 -2.120 (-8.797%) Non-current Assets
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Final) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | |
| Investment Properties | 0 | -- | 0 | 0 |
| Property, plant, equip. & others | 5,808 | -12.292% | 6,622 | 9,216 |
| Land & other Lease Assets | 18,731 | -0.234% | 18,775 | 2,842 |
| Intangible Assets | 0 | -- | 0 | 0 |
| Interests in Asso. & JCEs | 0 | -- | 0 | 0 |
| Other Non-current Assets | 45,763 | 4.332% | 43,863 | 49,223 |
| 70,302 | 1.504% | 69,260 | 61,281 | |
Current Assets
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Final) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | ||
| Inventories | 0 | -- | 0 | 0 | |
| Trade Receivables | 0 | -- | 0 | 0 | |
| Cash & Bank Balances | 1,067,575 | 1225.258% | 80,556 | 64,661 | |
| Other Current Assets | 141,450 | -22.128% | 181,645 | 121,316 | |
| Assets Held for Sale | 0 | -- | 0 | 0 | |
| 1,209,025 | 361.106% | 262,201 | 185,977 | ||
Current Liabilities
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Final) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | |||
| Trade Payables | 8,194 | 131.600% | 3,538 | 7,731 | ||
| S-T Debt & Leases | 724 | -98.537% | 49,499 | 4,019 | ||
| Other Current Liabilities | 123,742 | -42.006% | 213,370 | 66,182 | ||
| Liab asso w/ Assets Held for Sale | 0 | -- | 0 | 0 | ||
| 132,660 | -50.204% | 266,407 | 77,932 | |||
| Net Current Assets | 1,076,365 | -- | (4,206) | 108,045 | ||
| Total Assets Less Current Liabilities | 1,146,667 | 1662.639% | 65,054 | 169,326 | ||
Non-current Liabilities
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Final) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | ||||
| L-T Debt & Leases | 928 | 359.406% | 202 | 42,533 | |||
| Other Non-current Liabilities | 188,679 | -81.588% | 1,024,737 | 0 | |||
| 189,607 | -81.501% | 1,024,939 | 42,533 | ||||
Capital and Reserves
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Final) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | |||||
| Share Capital | 6,635 | 21.209% | 5,474 | 4,985 | ||||
| Reserves | 938,707 | -- | (977,934) | 106,826 | ||||
| Others | 0 | -- | 0 | 0 | ||||
| Shareholders' Funds | 945,342 | -- | (972,460) | 111,811 | ||||
| Non-controlling Interests | 11,718 | -6.815% | 12,575 | 14,982 | ||||
| Others | 0 | -- | 0 | 0 | ||||
| 957,060 | -- | (959,885) | 126,793 | |||||
Commitments and Contingent Liabilities
| 2026/06 - Interim RMB(K¥) | %Chg (Compare to Final) | 2025/12 RMB(K¥) | 2024/12 RMB(K¥) | |
| Commitments | -- | -- | 0 | 0 |
| Contingent Liabilities | -- | -- | 0 | 0 |
| Remarks: | Real time quote last updated: 11/09/2026 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB -230,823 |
| %Change | 372.079% |
| EPS / (LPS) | RMB -0.880 |
| NBV Per Share (¥) | RMB 2.850 |